Sometimes a yes or no answer is not enough. Today, quantitative applications mostly rely on laboratory based immuno-assays such as ELISA and are therefore limited in their accessibility and speed.
We are bringing ELISA to the point-of-care with our ELLI™ platform. ELLI™ is a USB-like device that enables accurate quantification of biomarkers and pathogens.
ELLI™ is a point-of-care technology that can suit a range of antibody-based assays. Our research-use-only assays target applications that require fast and accurate biomarker measurements:
Biosensorix aims to become the leading provider of next-generation diagnostic solutions. Our mission is to provide accurate and accessible solutions that will save lives and healthcare dollars.
